Carotid body peripheral chemoreceptor

The **carotid body peripheral chemoreceptor** is not a single molecule or classical receptor, but a cluster of specialized neuroendocrine cells (type I or glomus cells) located at the bifurcation of the common carotid artery[1][2][3][4][9]. These cells detect changes in arterial oxygen (mainly), carbon dioxide, and pH, triggering reflex increases in ventilation and sympathetic outflow to maintain cardiorespiratory homeostasis[1][2][3][7]. The key cellular event is inhibition of specific potassium channels and altered mitochondrial metabolism during hypoxemia, leading to membrane depolarization and neurotransmitter (acetylcholine, ATP, dopamine) release[2][3][6][7]. The result is activation of afferent nerve fibers (from the glossopharyngeal nerve), relaying chemosensory information to the respiratory centers. While the carotid body chemoreceptor plays a crucial physiological role and is implicated in several pathologies (such as sleep apnea, hypertension, heart failure), it is not a conventional druggable receptor, but rather a cellular complex and organ-level target[3][4][7]. Some interventional therapies under investigation (e.g., ablation, denervation) aim to modulate its whole-organ activity rather than discrete molecular targeting. Accordingly, "peripheral chemoreceptor on carotid body" is best considered a neuroendocrine cell cluster and **not a single targetable molecule** for drugs.

Other names

Carotid body chemoreceptorCarotid body type I cellGlomus cell (type I)Peripheral chemoreceptor of the carotid body

Not directly drug-targetable at the single-molecule level; effects mediated via modulation/destruction/denervation affecting cardiorespiratory reflex pathways